Skip to content
DataLookout
Menu

CIP-003NCT07327528

Multicentric Pilot Study for the Application of an Endourethral Device for the Treatment of Stress Urinary Incontinence

StatusRecruiting
PhaseNot applicable
SponsorRelief srl
Primary completion (estimated)

At risk: Primary completion moved at least 6 months later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Primary and study completion pushed from Dec 31, 2026 to Jun 30, 2027 Show 6 more changesShow less
    • Enrollment reopened
    • Enrollment increased: 20 → 30 participants
    • Eligibility criteria expanded, about 31 words
    • Study sites: 1 to 3
    • Secondary endpoints: details revised at 1 of 1 entry
    • Study title revised
  2. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

The safety of UroRelief
Timeframe: 18 months

Secondary (1)

Assess incontinence at 30 days, measured using the 24-hour pad weight test.

Arms and interventions

Endoscopic surgery for device installationExperimental

Endoscopic surgery for device installation

Devices: UroRelief, a sterile, single-use, endourethral medical device suitable for both men and women, which is positioned at the bladder neck for the treatment of stress incontinence.

Sites

3 sites in 1 country